Dr. Anthony Cultrara, MD

Dr. Cultrara practices at ENT and Allergy Associates in West Nyack, New York.

Dr. Cultrara's NPI, 1083619860, was assigned on June 17, 2005. Dr. Cultrara graduated from Rutgers New Jersey Medical School in 1998. Dr. Cultrara holds New Jersey license 25MA07615000.

Dr. Cultrara's primary practice is ENT and Allergy Associates, at 1 Cros Field Ave, West Nyack, NY 10994 in Rockland County. The practice phone is (914) 333-5800.

Dr. Cultrara's primary practice is ENT and Allergy Associates in West Nyack, New York. Dr. Cultrara is also affiliated with Virtua Mount Holly Hospital. The medical group on file is ENT and Allergy Associates. Dmand AI also links Dr. Cultrara to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cultrara practices, 4 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Cultrara's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Cultrara is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Cultrara's licenses on file in 3 states: New Jersey, Pennsylvania and New York.

Dmand AI lists chronic nasal allergies, chronic sinusitis, ear eustachian tube disorders, hearing loss and impairment, larynx and vocal cord disease, swimmer's ear, tinnitus and vertigo among the conditions Dr. Cultrara treats.

CMS data shows 1,844 Medicare services from Dr. Cultrara across 11 procedure codes in 2024, for 846 Medicare patients. Medicare paid $158,531 for them.

CMS counts 846 Medicare patients who saw Dr. Cultrara in 2024. The largest group is 65 to 74, with 340 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.10, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Cultrara's median patient age at 60, with 57% women.

In 2024, Dr. Cultrara wrote 1,688 Medicare Part D claims for 500 patients. 97% of them were for generic drugs. CMS names the drug for 1,583 of them, across 22 drugs with 11 or more claims each, at $45,964 in total drug cost. In 2023, CMS named 1,599 claims across 21 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Cultrara for performance year 2024, reported as part of a group. Dr. Cultrara accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 5 papers to Dr. Cultrara. Dr. Cultrara's most frequent co-authors are Nira A. Goldstein, MD, Gady Har-El, FACS, MD and Garrett H. Bennett, MD.

CMS Open Payments shows 170 general payments to Dr. Cultrara from 31 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Sanofi and Genzyme US Companies paid the most, $839.

Dmand AI lists 2 awards for Dr. Cultrara, most recently CMS Stage 1 EHR in 2013.

Dr. Cultrara graduated from Rutgers New Jersey Medical School in 1998. Dr. Cultrara is a member of NHS.

Dr. Cultrara is in network with 11 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.